Show results for
drug-design-and-development Videos
24 videos found
Feb. 10, 2023
DILIsym is a quantitative systems toxicology (QS) software designed for use during drug development to provide an indication of the potential drug-induced liver injury (DILI) hazard posed by individual molecules. It can also provide deeper insight into the mechanisms responsible for observed DILI responses at various stages of ...
Nov. 30, 2024
Find out how Thomas Ko’s latest research is developing immunotherapy drugs to treat ...
Mar. 26, 2022
Hanson Wade specializes in business intelligence and scientific research across a range of R&D areas. We deliver insight and connections to facilitate safe and effective drug development. Our four product areas comprise of 200+ conferences, Beacon, our clinical trial and data modules, Searchlight, our executive leader networks and Intelligence our bespoke market research. Together, these ...
Mar. 13, 2025
Advanced hematology oncology PDX models for AML and ALL drug development ...
Feb. 1, 2023
PSL's Microsphere Refiner is disrupting the way microsphere drugs are developed and manufactured, facilitating sustained release drug delivery over time. The MSR combines all the individual stages required in microsphere processing in a single equipment. Maximise Production Agility, Batch Repeatability, Product Recovery and Simplify the Scalability of your Microsphere Formulation by doing it the ...
Jan. 17, 2024
Probably the most important question we can ask is: “What is Your Clinical Development Strategy?” Well-designed and well-executed clinical trials are critical to the successful development of drugs, biomarkers, and devices. ...
Jun. 1, 2022
METTLER TOLEDO is a global manufacturer and marketer of precision instruments for use in laboratory, industrial and food retailing applications. Our laboratory solutions provide vital assistance in research and development, drug discovery and quality control. Our industrial solutions enhance your production, packaging and logistics capabilities and our retail solutions target the management of ...
Sep. 27, 2012
Hunan Huateng Pharmaceutical Co., Ltd. , founded in August 2013, is a high-tech enterprise dedicated to the research and development and production of high-end biomedical chemical products, as well as the development of precision targeted anti-tumor drugs. The company develops and produces thousands of products, including monodisperse and polydisperse PEG derivatives, high-end biochemical ...
Oct. 9, 2020
An exciting, minimally invasive urethral stricture treatment, Optilume drug-coated balloon was developed in response to severe patient and physician dissatisfaction with current stricture solutions. This proprietary technology combines balloon dilation and drug delivery, and is well-tolerated by patients. Rapid uptake of the highly lipophilic drug, paclitaxel, limits hyperactive cell ...
Jan. 3, 2023
For patients who have failed prior endoscopic treatment, today there is Optilume® — a breakthrough urethral drug-coated balloon treatment that dilates the urethral lumen and delivers paclitaxel directly to the stricture, significantly reducing the incidence of stricture recurrence. The Optilume® urethral drug-coated balloon was developed in response to severe patient and physician ...
Jan. 3, 2023
Delivering ultrasensitive biomarker measurement you can count on. Quanterix is re-engineering ultrasensitivity with the launch of the Simoa HD-X Analyzer™, the latest model fully automated Simoa bead-based immunoassay platform. Leveraging years of experience with the ground-breaking Simoa HD-1 Analyzer, the new flagship HD-X delivers major productivity improvements, greater user flexibility, ...
May. 2, 2020
BioConnection offers young and innovative biopharmaceutical companies access to State-of-the-art-GMP manufacturing facilities and a broad range of support services. We are a contract services and manufacturing organization for the development and manufacture (Filling and Freeze drying) of injectable (bio)pharmaceutical products. We have access to various GMP manufacturing facilities across ...
Oct. 11, 2021
SNNLive caught up with Matthew Jones, Managing Director of Business Development and Licensing of Dyadic International, Inc. (OTCQX: DYAI) at the Dawson James Small Cap Growth Conference 2016 in Jupiter, FL. For more information about Dyadic International, Inc., please visit: http://www.dyadic.com/ The interview may contain forward looking statements about Dyadic International, Inc. See Dyadic ...
Feb. 12, 2018
From discovery research to clinical evaluation, Champions Oncology combines innovative technology and unrivaled expertise to enable more efficient drug discovery and development workflow. Our data-driven research platforms empower scientists to create a comprehensive understanding of tumor cell biology, therapeutic dynamics and provide rapid clinical ...
Feb. 1, 2023
Subscribe to the Bio-Rad channel: https://www.youtube.com/user/BioRadLifeScience?sub_confirmation=1 For more information, http://www.bio-rad.com/yt/biopharma/stevenblakely or get instant expert help 1-800-4-BIORAD. Bio-Rad's Steven Blakely discusses some of the current challenges facing those doing drug discovery and development research. Biopharmaceutical researchers in drug discovery and ...
Oct. 3, 2018
Follow along as we give a high level overview of this incredible new technology that is disrupting the field of regenerative medicine, drug development and biomedical devices/implants. Questions about bringing this powerful design tool into your lab? ...
Aug. 20, 2021
Biotron Limited (ASX:BIT) held a webinar today to update investors on its latest news on its lead clinical stage antiviral drug BIT225. BIT225 has shown significant and clinically relevant activity in an animal model of COVID-19. The drug prevented the development of severe disease, reduced pro-inflammatory cytokines associated with "cytokine storms" that are linked to severe disease and ...
Jun. 2, 2022